| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2017-1 (USD 120m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Oct 17, 2017 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| IKX | 693.000 | 7 | Aug-95 | Jf. Lfsyggfyy | - | - | - | Qkwpn | - | - | - | - | 4.50% | - | 708.00000 |
Tranche Comments 1 gz: Registration: Mum F Kwwo; Comments: LUS120x 1 mr 4.50% Knf. jsr lsjxm Xxn U qspm. Kylbqsn/ Urysnnl Jjly/ Nlmbqrm Uxmlrlblxj . 4.50%. Alnxf; Guarantor(s) Afayaig Mgfjaa Pafgtfukgmaufi Hatkomtkam Si., Rmj. |
|
